fda semaglutide warning news october 2025 U.S. | The FDA has approved a new higher dose (7.2 mg) of Wegovy ( semaglutide) injection, Wegovy HD, for weight loss and long-term weight Recently Approved Wegovy Pill Expands

Take control of your wellness routine with HARMONIFY GLP-1 Plus Patches a convenient, transdermal alternative designed to naturally support metabolism, energy, and appetite balance

Evidence supports increased light tolerance, fewer and less severe phototoxic reactions, and improved QoL in EPP, and it accelerates and augments repigmentation when added to NBUVB in vitiligo

Peptide therapy may involve compounded medications prescribed for an individual patient when considered medically appropriate

GLP-1 Receptor Agonists May Reduce Rheumatoid Arthritis Activity and Cardiovascular Risk in People with Obesity Key Takeaways: GLP-1 receptor agonists were linked to reduced rheumatoid arthritis (RA) disease activity and improved cardiovascular risk factors in people with obesity or overweight

Regulated blood glucose leads to fewer cravings and more stable energy levels

doi: 10.1002/ptr.6465 98 ChenSJiangHWuXFangJ